Takashi Umeyama
Overview
Explore the profile of Takashi Umeyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sagawa T, Ohno S, Urata Y, Takemura T, Niki M, Kaneko Y, et al.
Respir Med Case Rep
. 2024 Nov;
52:102130.
PMID: 39524120
A 54-year-old woman with fever and cough presented with left upper lobe consolidation and para-aortic and hilar lymphadenopathies and was diagnosed with sarcoidosis, and her condition improved spontaneously. Over the...
2.
Miyazawa K, Umeyama T, Yoshimi A, Abe K, Miyazaki Y
Med Mycol J
. 2024 Sep;
65(3):75-82.
PMID: 39218650
The hyphal surface of cells of filamentous fungi is covered with cell wall, which is mainly composed of polysaccharides. Since the cell wall is the first structure to come in...
3.
Miyazawa K, Umeyama T, Takatsuka S, Muraosa Y, Hoshino Y, Yano S, et al.
Med Mycol
. 2024 Mar;
62(3).
PMID: 38429972
Hyphal pellet formation by Aspergillus species in liquid cultures is one of the main obstacles to high-throughput anti-Aspergillus reagent screening. We previously constructed a hyphal dispersion mutant of Aspergillus fumigatus...
4.
Miyazaki T, Hosogaya N, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, et al.
Microbiol Spectr
. 2023 May;
11(3):e0431122.
PMID: 37140398
Nelfinavir, an orally administered inhibitor of human immunodeficiency virus protease, inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) . We conducted a randomized controlled trial to evaluate...
5.
Sadamoto S, Mitsui Y, Nihonyanagi Y, Amemiya K, Shinozaki M, Murayama S, et al.
J Fungi (Basel)
. 2022 Apr;
8(4).
PMID: 35448568
Invasive fungal infection (IFI) has a high mortality rate in patients who undergo hematopoietic stem cell transplantation, and it is often confirmed by postmortem dissection. When IFI is initially confirmed...
6.
Nagi M, Tanabe K, Tanaka K, Ueno K, Nakayama H, Ishikawa J, et al.
JAC Antimicrob Resist
. 2022 Mar;
4(1):dlac018.
PMID: 35265841
Background: is an emerging fungal pathogen in immune-compromised hosts. Previously undetected isolates were successfully recovered from clinical specimens by adding sterols to the growth medium. The clinical isolates are unable...
7.
Tateno M, Umeyama T, Inukai T, Takatsuka S, Hoshino Y, Yamagoe S, et al.
Med Mycol J
. 2022 Feb;
63(2):27-35.
PMID: 35173102
Aspergillus lentulus was first reported in 2005 as a cryptic species of Aspergillus fumigatus, and since then, its resistance to azole drugs and the high mortality rate of infected individuals...
8.
Yamashita M, Ikeda M, Kato I, Ohama Y, Ando M, Ikemura M, et al.
Ann Clin Microbiol Antimicrob
. 2022 Feb;
21(1):5.
PMID: 35164794
Background: Protothecosis is a rare infection in humans and animals caused by the achlorophyllic algae Prototheca species. More than half of the protothecosis cases are cutaneous infections, and most cases...
9.
Kimura M, Asano-Mori Y, Sakoh T, Abe M, Ueno K, Hoshino Y, et al.
Antimicrob Agents Chemother
. 2022 Jan;
66(3):e0208121.
PMID: 35041512
Limited data are available on breakthrough fungemia, defined as fungemia that develops on administration of antifungal agents, in patients with hematological disorders. We reviewed the medical and microbiological records of...
10.
Miyazawa K, Umeyama T, Hoshino Y, Abe K, Miyazaki Y
Microbiol Spectr
. 2022 Jan;
10(1):e0006321.
PMID: 34985327
Filamentous fungi form multicellular hyphae, which generally form pellets in liquid shake cultures, during the vegetative growth stage. Because of these characteristics, growth-monitoring methods commonly used in bacteria and yeast...